Changing Cascade of Care for Hepatitis C in the Era of Direct-Acting Antivirals

被引：0
|
作者：
Chhatwal, Jag [1 ,2 ,3 ,4 ]
Chen, Qiushi [4 ]
Bethea, Emily [1 ,2 ]
Ayer, Turgay [5 ]
Zhuo, Yueran [4 ]
Hur, Chin [1 ,2 ]
Spaulding, Anne [6 ]
Kanwal, Fasiha [7 ]
机构：
[1] Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Gastrointestinal Div, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA
[5] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA
[6] Rollins Sch Publ Hlth, Druid Hills, GA USA
[7] Michael E Debakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1613
引用
收藏
页码：918A / 919A
页数：2
相关论文
共 50 条
  • [31] Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C
    Kieran, J.
    O'Leary, A.
    Norris, S.
    Walsh, C.
    Merriman, R.
    Houlihan, D.
    McCormick, P. A.
    McKiernan, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S229 - S230
  • [32] Hepatitis C care cascade in HIV patients at an urban clinic in the early direct-acting antiviral era
    Ma, Jimmy
    None, Lemuel
    Amornsawadwattana, Surachai
    Olsen, Margaret A.
    Wilson, Alexandria Garavaglia
    Presti, Rachel M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (09) : 834 - 842
  • [33] Future of hepatitis C therapy: development of direct-acting antivirals
    Dore, Gregory J.
    Matthews, Gail V.
    Rockstroh, Juergen
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 508 - 513
  • [34] Hepatitis C virus resistance to the new direct-acting antivirals
    Esposito, Isabella
    Trinks, Julieta
    Soriano, Vicente
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (10) : 1197 - 1209
  • [35] Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
    Torbjørn Wisløff
    Richard White
    Olav Dalgard
    Ellen J. Amundsen
    Hinta Meijerink
    Astrid Louise Løvlie
    Hilde Kløvstad
    PharmacoEconomics, 2018, 36 : 591 - 601
  • [36] Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
    Wisloff, Torbjorn
    White, Richard
    Dalgard, Olav
    Amundsen, Ellen J.
    Meijerink, Hinta
    Lovlie, Astrid Louise
    Klovstad, Hilde
    PHARMACOECONOMICS, 2018, 36 (05) : 591 - 601
  • [37] Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C
    Neokosmidis, Georgios
    Protopapas, Adonis A.
    Stogiannou, Dimitrios
    Filippidis, Athanasios
    Tziomalos, Konstantinos
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (01): : 58 - 66
  • [38] Comments on Cochrane Review on Direct-Acting Antivirals for Hepatitis C
    Lok, Anna S.
    Chung, Raymond T.
    Vargas, Hugo E.
    Kim, Arthur Y.
    Naggie, Susanna
    Powderly, William G.
    HEPATOLOGY, 2017, 66 (04) : 1016 - 1019
  • [39] New direct-acting antivirals for the treatment of chronic hepatitis C
    Jeong, Sook-Hyang
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2015, 58 (12): : 1154 - 1158
  • [40] HIV-Hepatitis C Virus Co-infection in the era of Direct-Acting Antivirals
    Bichoupan, Kian
    Dieterich, Douglas T.
    Martel-Laferriere, Valerie
    CURRENT HIV/AIDS REPORTS, 2014, 11 (03) : 241 - 249
12345